Jul 2, 2025 | Commercial Payor Audits, federal investigations, Health Care, Health Care Fraud, Medicare and Medicaid
The attorneys at Chilivis Grubman represent a wide variety of healthcare providers and suppliers in connection with Medicare audits and overpayment appeals. Clients often ask us how long a CMS contractor has to reopen a claim for purposes of conducting a post-payment...
Jun 30, 2025 | False Claims Act, federal investigations, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid, White Collar Crime
Nearly every summer, the U.S. Department of Justice (DOJ) announces a large-scale healthcare fraud “takedown.” The DOJ announced its latest such action on June 30, 2025. In its press release, the DOJ announced that it had charged 324 defendants in...
Jun 15, 2025 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid, White Collar Crime
Last month, North Carolina Attorney General Jeff Jackson announced that his office had reached a consent judgment of over $4.7 million with Kernersville-based healthcare provider Steven Osbey to resolve an alleged Medicaid fraud scheme. 💰 What Happened According to...
Jun 7, 2025 | False Claims Act, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid
On June 3, the United States Attorney’s Office for the Southern District of Florida in Miami announced that it had filed a complaint under the False Claims Act (FCA) against Florida-based medical billing company AIMA. According to the DOJ’s complaint,...
May 27, 2025 | Medicare and Medicaid
Follow along with our interactive transcript below. By entering email and watching this free webinar, you give Chilivis Grubman permission to periodically contact you via email with additional educational and informational material. We will not share your email with...
Apr 16, 2025 | Medicare and Medicaid
Donald Trump signed an executive order on Tuesday directing the Department of Health and Human Services to work with Congress on amending a key component of Medicare’s new drug price negotiation authority. The directive specifically targets a timeline that drugmakers...
